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a  b  s  t  r  a  c  t
Trichothecene  mycotoxins,  potent  translational  inhibitors  that  are  associated  with  human
food poisonings  and damp-building  illnesses,  are  of  considerable  concern  to animal  and
human health.  Food  refusal  is  a hallmark  of  exposure  of experimental  animals  to deoxyni-
valenol  (DON)  and other  Type  B trichothecenes  but  less  is  known  about  the  anorectic
effects  of  foodborne  Type  A trichothecenes  (e.g.,  T-2  toxin,  HT-2  toxin),  airborne  Type  D
trichothecenes  (e.g.,  satratoxin  G  [SG])  or functionally  analogous  metabolites  that  impair
protein synthesis.  Here,  we utilized  a well-described  mouse  model  of  food  intake  to  com-
pare the anorectic  potencies  of  T-2  toxin,  HT-2  toxin,  and  SG to that  of emetine,  a  medicinal
alkaloid  derived  from  ipecac  that  inhibits  translation.  Intraperitoneal  (IP)  administration
with  T-2  toxin,  HT-2  toxin,  emetine  and  SG  evoked  anorectic  responses  that  occurred  within
0.5  h  that  lasted  up to  96, 96,  3  and 96  h,  respectively,  with  lowest  observed  adverse  effect
levels  (LOAELs)  being  0.1, 0.1, 2.5  and  0.25  mg/kg  BW,  respectively.  When  delivered  via nat-
ural routes  of  exposure,  T-2  toxin,  HT-2  toxin,  emetine  (oral)  and SG  (intranasal)  induced
anorectic  responses  that  lasted  up to  48, 48,  3 and  6 h, respectively  with  LOAELs  being 0.1,
0.1,  0.25,  and  0.5 mg/kg  BW,  respectively.  All  four  compounds  were  generally  much  more
potent than DON  which  was previously  observed  to have LOAELs  of 1 and  2.5  mg/kg  BW
after  IP and  oral  dosing,  respectively.  Taken together,  these  anorectic  potency  data  will
be valuable  in discerning  the  relative  risks  from  trichothecenes  and  other  translational
inhibitors  of  natural  origin.
©  2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
the  CC  BY-NC-N
Abbreviations: NOAELs, no adverse effect levels; AGRP, agouti-related
protein; CART, amphetamine-regulated transcript; DON, vomitoxin,
deoxynivalenol; DMSO, dimethyl sulfoxide; IL-1, interleukin-1;  IL-6,
interleukin-6; LOAELs, lowest adverse effect levels; MC4R, melanocortin
4  receptor; NPY, neuropeptide Y; POMC, pro-opiomelanocortin; SG, satra-
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1. Introduction
Trichothecenes, a family of toxic sesquiterpenoid
metabolites produced by Fusarium, Stachybotrys and other
fungi, cause a spectrum of adverse effects in experimen-
tal animals that include food refusal, growth suppression,
emesis, neuroendocrine changes, and immunotoxicity [1].
Trichothecenes can be encountered both in food and the
indoor environment and have been structurally classi-
ﬁed into several groups with Types A, B and D being
cess article under the CC BY-NC-ND license (http://creativecommons.org/
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(MSU-IACUC). Female B6C3F1 mice were obtained fromW.  Wu  et al. / Toxicolo
f greatest signiﬁcance to public health. The Type B tri-
hothecenes are frequently encountered in wheat, barley,
aize and rice that are infected by the fungus Fusarium
raminearum with deoxynivalenol (DON, vomitoxin) being
etected most commonly and at the highest concentra-
ions [2,3]. DON and other Type B trichothecenes are stable
uring milling and processing and thus can be present in
nimal and human food [4]. The potential for suppression
f food intake and resultant growth retardation by DON and
elated Type B trichothecenes is of particular concern from
he perspective of human and animal health and has been
he basis for their regulation by governments around the
orld [5,6].
DON-induced food refusal in mice has been linked
o modulation of anorexigenic (e.g., pro-opiomelano-
ortin [POMC], melanocortin 4 receptor [MC4R] and
mphetamine-regulated transcript [CART]) expression
ithin hypothalamic neurons [7]. Further studies by
his group, revealed the presence of NUCB2/nesfatin-1
eurons in various brain regions, and their activation dur-
ng DON intoxication [8]. Importantly, nesfatin-1 evokes
norectic responses after both peripheral and central
xposure [9] as well as activation of NUCB2/nesfatin-
 neurons in the [7–10]. Satiety hormones secreted by
nteroendocrine cells located in the intestinal epithe-
ium such as cholecystokinin (CCK) and peptide YY3-36
PYY3-36) appear to be critical driving factors in afore-
entioned anorexigenic pathways in the brain [11–13].
hese hormones can act in paracrine fashion to stimu-
ate speciﬁc receptors located on either vagus nerve or
ndocrine fashion via the area postrema, eventually evok-
ng anorectic responses [14]. In prior studies, elevated
lasma CCK and/or PYY3-36 concentrations were corre-
ated to Type B ketotrichothecene-induced anorexia in
ouse [15,16]. Furthermore, inhibition of NPY2 receptor or
CK1 and CCK2 receptor attenuated DON-induced anorexia
levated plasma CCK and/or PYY3-36 concentrations cor-
elate to Type B ketotrichothecene-induced anorexia in
ouse and furthermore receptor inhibition studies sup-
ort a role for these hormones in this adverse effect
15,16].
Type A trichothecenes are produced by two  Fusa-
ium head blight fungi, Fusarium langsethiae and Fusarium
porotrichioides. Although less commonly encountered in
ereal grains than the Type B group, they are much more
otent toxins in acute toxicity studies of several animal
odels and in cell culture assays, with T-2 toxin (Fig. 1A)
eing considered one of the most potent [17,18]. T-2 toxin
oxicosis outbreaks in farm animals have been reported
n many countries including Canada, United States and
apan [19–21]. T-2 toxin’s capacity to cause human food
oisoning is demonstrated by a documented food poi-
oning outbreak in China that involved 97 persons out
f an estimated 165 persons that consumed Fusarium-
ontaminated rice that contained T-2 toxin in the range of
.18–0.42 mg/kg [22]. T-2 toxin readily induces anorectic
ffects following oral, sublingual, intravenous (iv), subcuta-
eous (sc) and intraperitoneal (IP) in several animal species
17,23–27]. HT-2 toxin (Fig. 1B) differs from T-2 toxin by
eing hydroxylated at the C-4 position but has compara-
le toxicity to the parent toxin [18,28]. To date there haverts 2 (2015) 238–251 239
been no studies concerning the anorectic potential of HT-2
toxin.
Type D or macrocyclic trichothecenes are produced by
the black mold Stachybotrys chartarum and can be encoun-
tered in dust and air of water-damaged buildings [3].
Members of the Type D group have equivalent or greater
toxicity to T-2 toxin in cell culture assays [29]. Satra-
toxin G (SG) (Fig. 1C), is one of the most potent Type D
trichothecenes. Intranasal installation has been shown to
highly destructive to olfactory epithelium of mice and mon-
key resulting in the loss of the sense of smell [30–33].
Although the potential exists for intranasally instilled SG
and other Type D trichothecenes to enter the gut following
the action of ciliated respiratory epithelium, their effects
on food intake have not been assessed.
Trichothecene-induced food refusal might be linked to
their capacity to inhibit translation. Emetine is a natural
alkaloid produced from ipecacuanha that has been phar-
macologically used to induce emesis against toxic agent
ingestion, as well as for its anti-cough and anti-amoebiasis
effects [34,35]. Like trichothecenes, emetine has the poten-
tial to block protein synthesis by binding to ribosomal
subunits [36]. Thus emetine might be useful in mechanism
studies as a functional analog of the otherwise structurally
unrelated trichothecenes, however, its anorectic effects are
not well-characterized. The objective of this study was to
compare the anorectic potencies of T-2 toxin, HT-2 toxin,
SG and emetine in a mouse bioassay developed previ-
ously for the Type B trichothecenes [37,38]. Both parenteral
(intraperitoneal [IP]) and natural (oral gavage for T-2, HT-
2, emetine and intranasal for SG) routes of exposure were
employed. The results indicate that all four toxic agents:
(1) induced anorectic responses, (2) were differentially
affected by exposure route and (3) were generally much
more potent than DON.
2. Materials and methods
2.1. Toxins and drugs
T-2 toxin, HT-2 toxin and emetine were purchased from
Enzo Life Sciences with purity ≥98%. SG was isolated and
purity was veriﬁed by electrospray ionization/collision-
induced dissociation tandem mass spectroscopy as pre-
viously described [39]. T-2 toxin and HT-2 toxin were
dissolved in 1% dimethyl sulfoxide (DMSO) in ﬁlter-
sterilized phosphate buffered saline (PBS). SG and emetine
were dissolved in ﬁlter-sterilized PBS.
2.2. Laboratory animals
Animal treatment followed National Institutes of Health
guidelines and were approved by the Michigan StateCharles River Breeding (Portage, MI)  at 10–12 wk  of age and
housed individually in polycarbonate cages in a room main-
tained at 21–24 ◦C and 40–55% relative humidity under a
12 h light (6:00–18:00 h)/dark (18:00–6:00 h) cycle.
240 W.  Wu et al. / Toxicology Reports 2 (2015) 238–251
), HT-2 tFig. 1. Structures of T-2 toxin (A
2.3. Experimental design
The general experimental design for assessing anorec-
tic potencies (Fig. 2) was based on previously described
protocols [37,38]. Brieﬂy, mice were acclimated for 1 wk
after arriving and randomly divided into different groups
according to body weight 1 d before experiment. On the day
of the experiment, groups of mice (n = 6) were fasted butoxin (B), SG (C) and emetine (D).
water provided ad lib from 10:00 h to 18:00 h. At 18:00 h,
toxins were administered to mice in 100 l volumes by
IP injection with a sterile 27 G, 0.5 in. needle, oral gavage
using a sterile 22 G, 1.5 in. disposable feeding tube (Instech
Solomon; Plymouth Meeting, PA) or by intranasal expo-
sure as previously described [32]. Food was  then provided
and consumption monitored. Dose selection was based
on preliminary range ﬁnding studies. Food intake was
W.  Wu  et al. / Toxicology Reports 2 (2015) 238–251 241
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onitored for varying lengths of time up to 96 h depend-
ng on the duration of anorexia observed in preliminary
xperiments.
For T-2 toxin, groups of mice were dosed with 0, 0.01,
.1, 0.5 and 1 mg/kg BW T-2 toxin in 100 l 1% DMSO by
oth IP injection and oral gavage. Mice were then imme-
iately provided six pre-weighed food pellets (≈21 g) and
ood intake measured at 0.5, 1, 2, 3, 6, 16, 24, 48, 72 and
6 h after IP exposure or 0.5, 1, 2, 3, 6, 16, 24 and 48 h after
ral exposure, respectively. Preliminary experiments indi-
ated that feeding responses in mice treated with 1% DMSO
n PBS and PBS alone did not differ. The approach for HT-2
oxin was identical to T-2 toxin.
For SG, groups of mice were given with 0, 0.025, 0.25,
 and 2.5 mg/kg BW of toxin in 100 l PBS by IP injection
r 0, 0.005, 0.05, 0.25 and 0.5 mg/kg BW of toxin in 100 l
BS by intranasal exposure. Mice were then immediately
rovided six pre-weighed food pellets (≈21 g) or two pre-
eighed food pellets (≈7 g) and food intake measured at
.5, 1, 2, 3, 6, 16, 24, 48, 72 and 96 h after IP exposure or 0.5,
, 2, 3, 6 and 16 h after intranasal exposure, respectively.
For emetine, groups of mice were given with 0, 0.05, 0.5,
.5 and 5 mg/kg BW of emetine in 100 l PBS by IP injection
r 0, 0.025, 0.25, 1 and 2.5 mg/kg BW of emetine in 100 l
BS by oral exposure. Mice were then immediately pro-
ided two pre-weighed food pellets (≈7 g) and food intake
easured at 0.5, 1, 2, 3, 6 and 16 h after both IP and oral
xposure.
.4. Statistics
Data were plotted and statistically analyzed using
igmaPlot 11 for Windows (Jandel Scientiﬁc; San Rafael,
A). Means were considered signiﬁcantly different at
 < 0.05. Food intake at speciﬁc time points was analyzed
y one-way ANOVA using Holm–Sidak Method to deter-
ine signiﬁcant differences between treatments and theespective control. Two way repeated ANOVA (one-factor)
sing Holm–Sidak Method was used to analyze signiﬁcant
ifferences in food consumption as compared to the control
ver time. 10:00 to 18:00 h on day 1. At 18:00 h, mice were treated with toxin or
measured up to 0–96 h.
3. Results
After IP administration with T-2 toxin, marked reduc-
tions in food intake were observed in mice at 0.1, 0.5
and 1 mg/kg BW during 0.5–96 h time period whereas
0.01 mg/kg BW had no effect (Fig. 3A and B). The 0.1 mg/kg
BW dose evoked 51, 44, 52, 52 and 38% reduction in cumu-
lative food intake at 0.5, 1, 2, 3 and 6 h, respectively, with
no differences being observed after 16 h. The 0.5 mg/kg BW
dose caused 90, 65, 63, 66, 86 and 70% reduction in cumu-
lative food intake at 0.5, 1, 2, 3, 6 and 16 h, respectively.
From 16 to 96 h, there was a trend toward moderately
increased food consumption. Dramatic reductions in food
intake were observed for the 1 mg/kg BW dose after 0.5
(95%), 1 (83%), 2 (76%), 3 (78%), 6 (90%), 16 (93%) and
24 h (92%), respectively. From 24 to 96 h, there was again
a moderate recovery in food intake. However, signiﬁcant
reductions in cumulative food intake were still evident at
96 h for both 0.5 and 1 mg/kg BW doses.
Upon oral dosing with T-2 toxin, food intake was
markedly reduced at 0.1, 0.5 and 1 mg/kg BW during
0.5–48 h while 0.01 mg/kg BW was without effect (Fig. 4A
and B). The 0.1 mg/kg BW dose caused 58, 50, 46 and 43%
reduction in cumulative food intake at 0.5, 1, 2 and 3 h,
respectively, with no differences being observed after 6 h.
The 0.5 mg/kg BW dose caused 63, 54, 47, 46 and 44%
reduction in cumulative food intake at 0.5, 1, 2, 3 and
6 h, respectively. Marked reductions in food intake were
observed at 1 mg/kg BW after 0.5 (76%), 1 (59%), 2 (57%),
3 (60%), 6 (59%), 16 (62%) and 24 h (57%), respectively.
From 24 to 48 h, there was a trend toward increased food
consumption. However, this latter group still did not fully
compensate for initial food refusal by 48 h suggesting T-2s
effects were long-lasting.
When the anorectic effects of IP exposure to HT-2 toxin
was evaluated, signiﬁcant reductions in food intake were
seen at 0.1, 0.5 and 1 mg/kg BW during 0.5–96 h, whereas
effects were not observed for 0.01 mg/kg BW (Fig. 5A and
B). The 0.1 mg/kg BW dose evoked 68, 53, 45, 53 and 35%
reduction in cumulative food intake at 0.5, 1, 2, 3 and
6 h, respectively, with no differences being observed after
242 W.  Wu et al. / Toxicology Reports 2 (2015) 238–251
Fig. 3. IP exposure to T-2 toxin impairs food intake. (A) Short term (0–16 h) food refusal induced by IP T-2 toxin exposure. Data are mean ± SEM (n = 6/gp).
Food  intake at speciﬁc time points was analyzed by one-way ANOVA using Holm–Sidak Method to determine signiﬁcant differences between an individual
treatment and the vehicle control. The symbol * indicates difference in food consumption as compared to the control (p < 0.05) for a given time period. (B)
Long  term (0–96 h) food refusal induced by IP T-2 toxin exposure. Data are mean ± SEM (n = 6/gp). Two  way repeated ANOVA (one-factor) using Holm–Sidak
Method was used to analyze signiﬁcant differences in food consumption as compared to the control over time. Symbols: * indicates difference in cumulative
food consumption relative to the control at speciﬁc time point (p < 0.05) and D indicates difference in cumulative food consumption relative to the 0.5 h
time  point within a given dose (p < 0.05).
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Big. 4. Oral exposure to T-2 toxin impairs cumulative food intake for up 
B)  Long term (0–96 h) food refusal induced by oral T-2 toxin exposure. E
6 h. The 0.5 mg/kg BW dose caused 83, 67, 61, 66, 77 and
3% reduction in cumulative food intake at 0.5, 1, 2, 3,
 and 16 h, respectively. A trend toward increased food
onsumption was observed after 16 h, and the 0.5 mg/kg
W group compensated for initial food refusal by 48 h(A) Short term (0–16 h) food refusal induced by oral T-2 toxin exposure.
nt was conducted and data analyzed as described in Fig. 3 legend.
(Fig. 5B). Marked reductions in food intake were observed
at 1 mg/kg BW after 0.5 (86%), 1 (67%), 2 (60%), 3 (67%),
6 (84%), 16 (69%) and 24 h (65%), respectively. From 24
to 96 h, there was  a trend toward increased food con-
sumption. However, as observed for T-2 toxin, by 96 h
244 W.  Wu et al. / Toxicology Reports 2 (2015) 238–251
 96 h. (A
riment wFig. 5. IP exposure to HT-2 toxin impairs cumulative food intake for up to
Long  term (0–96 h) food refusal induced by IP HT-2 toxin exposure. Expe
this group still did not fully compensate for initial food
refusal.
Signiﬁcant reductions in food intake were also observed
after oral exposure to HT-2 toxin at 0.1, 0.5 and 1 mg/kg
BW (Fig. 6A) but, 0.01 mg/kg BW dose had no effect. The
0.1 mg/kg BW dose reduced cumulative food intake 60 and
49% at 0.5 and 1 h, respectively, with no differences being
observed after 2 h. Reduced food intake was observed at) Short term (0–16 h) food refusal induced by IP HT-2 toxin exposure. (B)
as conducted and data analyzed as described in Fig. 3 legend.
0.5 mg/kg BW after 0.5 (86%), 1 (72%), 2 (69%), 3 (65%) and
6 h (48%), respectively, with no differences being observed
after 16 h. 1 mg/kg BW dose evoked 90, 66, 68, 64, 60 and
33% reduction in cumulative food intake at 0.5, 1, 2, 3, 6
and 16 h, respectively. An increased rate of food consump-
tion was observed for HT-2 toxin-treated groups during
16–48 h thus compensating for initial food refusal by 48 h
(Fig. 6B).
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Fig. 6. Oral exposure to HT-2 toxin impairs cumulative food intake for up to 48 h. (A) Short term (0–16 h) food refusal induced by oral HT-2 toxin exposure.
(  Experim
d
t
MB)  Long term (0–96 h) food refusal induced by oral HT-2 toxin exposure.IP exposure to SG at 0.25, 1 and 2.5 mg/kg BW caused
ecreased food consumption in mice during 0.5–96 h while
he 0.025 mg/kg BW dose had no effect (Fig. 7A and B).
arked reductions in food intake were observed after 0.5ent was  conducted and data analyzed as described in Fig. 3 legend.(67, 60 and 72%), 1 (50, 54 and 57%), 2 (45, 51 and 56%), 3
(42, 51 and 59%), 6 (42, 60 and 81%) and 16 h (25, 69 and
89%) at 0.25, 1 and 2.5 mg/kg BW,  respectively. From 24 to
96 h, there is a trend toward increased food consumption at
246 W.  Wu et al. / Toxicology Reports 2 (2015) 238–251
 (A) Sho
ted and Fig. 7. IP exposure to SG impairs cumulative food intake for up to 96 h.
(0–96  h) food refusal induced by IP SG exposure. Experiment was conduc
1 and 2.5 mg/kg BW doses (Fig. 7B). However, by 96 h these
groups still did not fully compensate for initial food refusal.
Intranasal exposure to SG at 0.5 mg/kg BW caused 70, 56
and 52% reduction in cumulative food intake at 0.5, 1 and
2 h, respectively, with no differences being observed after
3 h (Fig. 8). Comparatively, the 0.005, 0.05 and 0.25 mg/kg
BW doses had no effect.rt term (0–16 h) food refusal induced by IP SG exposure. (B) Long term
data analyzed as described in Fig. 3 legend.
Food intake was reduced in mice exposed IP to eme-
tine at 2.5 and 5 mg/kg BW,  but 0.05 and 0.5 mg/kg BW
had no effect (Fig. 9). The 2.5 mg/kg BW evoked 50%
reduction in cumulative food intake at 0.5 h with no dif-
ferences being observed after 1 h. Marked reductions in
food intake were observed at 5 mg/kg BW after 0.5 (71%), 1
(58%), 2 (57%) and 3 h (54%), respectively. Beginning at 6 h,
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bserved.
Following oral exposure to emetine, signiﬁcant food
eductions were observed at 0.25, 1 and 2.5 mg/kg BW
uring 0.5–6 h, while 0.025 mg/kg BW dose had no effect
Fig. 10). Emetine at 0.25 mg/kg BW evoked 54 and 49%
eduction in cumulative food intake at 0.5 and 1 h, respec-
ive, with no differences being observed after 2 h. Marked
eductions in food intake were observed after 0.5 (65 and
6%), 1 (51 and 66%), 2 (57 and 56%) and 3 h (48 and 56%)
t 1 and 2.5 mg/kg BW,  respectively, with no differences
eing observed beginning at 6 h.
. Discussion
Reduced food intake resulting from trichothecene expo-
ure with consequential impairment of growth is a major
oncern from the perspective of animal and human health.
his study is novel because it is the ﬁrst to systematically
ompare the anorectic potentials of T-2 toxin, HT-2 toxin
nd SG and in a deﬁned animal model and relate these to a
tructurally unrelated translational inhibitor, emetine, that
as a long history of medicinal use. The results revealed
hat T-2 toxin, HT-2 toxin, SG and emetine caused anorecticperiment was conducted and data analyzed as described in Fig. 3 legend.
effects in the mouse with different response kinetics and
durations. Furthermore, the anorectic responses to these
toxins were differentially affected relative to dose and/or
duration when delivered by parenteral or natural exposure
routes. The no adverse effect levels (NOAELs) and lowest
adverse effect levels (LOAELs) for T-2 toxin, HT-2 toxin, SG
and emetine following IP and oral exposure are summa-
rized in Table 1. These data suggest that anorectic potencies
followed approximate rank orders of T-2 toxin = HT-2
toxin > SG > emetine for IP exposure and T-2 toxin = HT-2
toxin > emetine > SG for oral or intranasal exposure. Impor-
tantly, these compounds were generally much more potent
than DON which was previously found to have a LOAELS of 1
and 2.5 mg/kg BW after IP and oral dosing, respectively [38].
Anorectic potency data that have been previously
reported for the studied compounds are summarized in
Table 2. The anorectic NOAEL and LOAEL of T-2 toxin were
previously reported to be 1 and 3 mg/kg BW in rat follow-
ing oral exposure [23]. Recently, the anorectic LOAEL for
oral exposure to this toxin in the mouse was  reported to
be 0.5 mg/kg BW [25]. The prolonged duration observed
here (48 h) following oral exposure is very consistent with
this aforementioned study. Some of these values were
higher than the data presented here for T-2 toxin (0.01 and
248 W.  Wu et al. / Toxicology Reports 2 (2015) 238–251
Fig. 9. IP exposure to emetine impairs cumulative food intake for up to 6 h. Experiment was  conducted and data analyzed as described in Fig. 3 legend.
Table 1
Comparison of anorectic effects of T-2 toxin, HT-2 toxin, satratoxin G and emetine in mouse.
Toxin (mg/kg BW)  IP Oral Intranasal
NOAELa LOAELb NOAELa LOAELb NOAELa LOAELb
T-2 toxin 0.01 0.1 0.01 0.1 – –
HT-2  toxin 0.01 0.1 0.01 0.1 – –
SG  0.025 0.25 – – 0.25 0.5
0.0Emetine 0.5 2.5 
a NOAEL, no observed adverse effect level.
b LOAEL, lowest observed adverse effect level.0.1 mg/kg BW,  respectively). For emetine, the LOAEL for
anorectic responses were reported to be 3 and 0.1 mg/kg
BW in dog following iv and interventricular exposure,
respectively [34]. Differences in experimental design and
Table 2
Previously reported anorectic effects of T-2 toxin and emetine.
Toxin Species Route NO
T-2 toxin Mouse Oral n.d
T-2 toxin Rat Oral 1 
T-2 toxin Rabbit Oral n.d
T-2 toxin Cat sc n.d
T-2 toxin Cat Oral n.d
Emetine Dog iv n.d
Dog intraventricular n.d25 0.25 – –animal species in absorption, distribution, metabolism, and
excretion of T-2 toxin and emetine could explain the differ-
ences observed between these prior studies and the current
investigation.
AEL (mg/kg BW)  LOAEL (mg/kg BW)  Study
. 0.5 [25]
3 [23]
. 2 [26]
. 0.05 [27]
. 0.08 [24]
 3 [34]
 0.1
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The anorectic NOAEL and LOAEL of HT-2 toxin and SG
ollowing IP and oral or intranasal exposure presented
ere are the ﬁrst published values for any species. These
ata indicate that the kinetics and dose-dependency of the
norectic responses to T-2 toxin and HT-2 toxin were sim-
lar. Anorexia occurred at both 0.5 h but lasted 96 h and
8 h following IP and oral exposure, respectively. T-2 toxin
s rapidly and almost completely biotransformed to HT-2
oxin after exposure in dogs [40] and rats [41] and similar
etabolic capabilities can be found in mouse microsomes
42]. Therefore, the equivalent anorectic potencies of these
wo compounds might be due to efﬁcient biotransforma-
ion of T-2 toxin. In contrast to the Type A trichothecenes,
he kinetics of the anorectic responses to SG following IP
nd intranasal exposure were quite different lasting 96 h
s 2 h, respectively. While no toxicokinetic data are avail-
ble relative to IP exposure to SG, in a prior study [43],
t was observed that following intranasal exposure of the
ouse to SG 0.5 mg/kg BW SG, the highest plasma toxin
evels were detected within 5 min  and returned to basal
evels by 2 h, which was consistent with transient anorexia
nduction by SG observed here.
Using the mouse model employed herein, our lab-
ratory demonstrated in prior work that upstreamperiment was conducted and data analyzed as described in Fig. 3 legend.
mechanisms for central anorexigenic signaling by DON
and other Type B trichothecenes is likely to involve secre-
tion of two satiety hormones by gut enteroendocrine cells,
CCK and PYY3-36 [15,16]. T-2 toxin has been shown to
induce c-Fos in key brainstem and hypothalamic nuclei
indicating that, like DON, this toxin targets the cen-
tral nervous system and evoke anorexia [25]. T-2 toxin
also activates central anorectic pathways by stimulating
NUCB2/nesfatin-1 expressing neurons in the hypothalamic
nuclei and brainstem. Thus, as observed for DON, activation
in the hypothalamus likely participates in T-2 toxin-
induced anorectic responses. It might be speculated that
CCK and PYY3-36 are similarly involved in anorexia induc-
tion by the panel of compounds tested here. Trichothecenes
are also known to induce gene expression and release
of proinﬂammatory cytokines including interleukin-1
(IL-1), interleukin-6 (IL-6) and tumor necrosis factor-
(TNF-) [1], these cytokines can also contribute to anorexia
induction by both peripheral and central administration
[44–47]. T-2 toxin and SG were reported to cause mRNA
levels of IL-1, IL-6 and TNF- upregulation in rodents
[25,39,48,49]. It is therefore possible that anorexia induc-
tion by T-2 toxin, HT-2 toxin and SG might also be mediated
in part by sickness responses to these cytokines.
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It was notable that emetine also had anorectic effects
and was much more potent at reducing food intake when
delivered orally than parenterally. Emetine is the princi-
pal alkaloid in ipecac syrup derived from ipecacuana plants
and has medicinal properties that include gastrointesti-
nal decontamination by induction of emesis as well as
treatment of amoebiasis and malaria [50]. Ipecac has, how-
ever, been used as a drug of abuse by individuals with
eating disorders such as anorexia nervosa and bulimia
and therefore, its use has been discouraged and it is no
longer available over the counter in the U.S. The greater
efﬁcacy of emetine following oral delivery as compared
to parenteral administration suggests contact with gut
enteroendocrine cells is required for the anorectic effects.
It is further notable that emetine inhibits translation by
interacting with the E-site of the ribosomal subunit thereby
blocking mRNA/tRNA translocation [51]. Interestingly, this
compound can block ribosomal binding of T-2 toxin in
eukaryotic cells [52,53]. Thus, it might be speculated that
emetine and trichothecenes evoke food refusal by causing
metabolic dysfunction through protein synthesis inhibition
in enteroendocrine cells which are known to rapidly turn
over, however, this will require further study.
Taken together, the results presented here indicate that
T-2 toxin, HT-2 toxin, SG and emetine dose-dependently
evoked anorectic responses in the mouse. Measurement
of the anorectic potencies of these toxins will be valu-
able in predicting their potentials to cause food refusal and
resultant growth suppression in animals and humans. It is
also important to note that all of the toxins tested here
were more effective at reducing food intake than DON.
We recognize that the latter interpretation must be made
cautiously given the inherent limitations of comparing the
results of two  different studies. Future studies should focus
on the underlying mechanisms for toxin-induced anorexia,
particularly in regard to neuroendocrine hormones and
cytokines. From animal and public health perspectives, the
comparative anorectic potency data presented here could
be useful for establishing toxic equivalency factors for tri-
chothecenes as well as other natural translation inhibitors.
Furthermore, studies such as this will improve our under-
standing of how these compounds adversely affect humans
and animals.
Transparency document
The Transparency document associated with this article
can be found in the online version.
Acknowledgements
We  would like to acknowledge the assistance of Erica
Clark and Mary Rosner. This study was supported by USDA
NIFA Award (2011-0635), USDA Wheat and Barley SCAB
Initiative Award 59-0206-9-058 and by Public Health
Service Grant ES3358 from the National Institutes of
Health. WW was supported by National Natural Science
Foundation of China (31402268), the Priority Academic
Development Program of Jiangsu Higher Education
[
[rts 2 (2015) 238–251
Institutions, Natural Science Foundation of Jiangsu
Province of China (BK20140691).
References
[1] J.J. Pestka, Toxicological mechanisms and potential health effects
of deoxynivalenol and nivalenol, World Mycotoxin J. 3 (2010)
323–347.
[2] M.  Maresca, From the gut to the brain: journey and pathophy-
siological effects of the food-associated trichothecene mycotoxin
deoxynivalenol, Toxins 5 (2013) 784–820.
[3] J.J. Pestka, Deoxynivalenol: mechanisms of action, human exposure,
and toxicological relevance, Arch. Toxicol. 84 (2010) 663–679.
[4] L.S. Jackson, L.B. Bullerman, Effect of processing on Fusarium myco-
toxins. Impact of processing on food safety, Adv. Exp. Med. Biol. 459
(1999) 243–261.
[5] R.A. Canady, R.D. Coker, S.K. Rgan, R. Krska, T. Kuiper-Goodman, et al.,
Deoxynivalenol. Safety evaluation of certain mycotoxins in food,
in:  Fifty-sixth Report of the Joint FAO/WHO Expert Committee on
Food Additives, International Programme on Chemical Safety, World
Health Organization, Geneva, 2001, pp. 420–555.
[6] EFSA, Statement on the risks for public health related to a possi-
ble  increase of the maximum level of deoxynivalenol for certain
semi-processed cereal products, EFSA J. 11 (12) (2013), 3490,
56 pp.
[7] C. Girardet, M.S. Bonnet, R. Jdir, M.  Sadoud, S. Thirion, et al.,
The food-contaminant deoxynivalenol modiﬁes eating by targeting
anorexigenic neurocircuitry, PLoS ONE 6 (2011) e26134.
[8] S. Gaige, M.S. Bonnet, C. Tardivel, P. Pinton, J. Trouslard, et al.,
c-Fos  immunoreactivity in the pig brain following deoxynivalenol
intoxication: focus on NUCB2/nesfatin-1 expressing neurons, Neu-
rotoxicology 34 (2013) 135–149.
[9] S. Oh, H. Shimizu, T. Satoh, S. Okada, S. Adachi, et al., Identiﬁcation
of nesfatin-1 as a satiety molecule in the hypothalamus, Nature 443
(2006) 709–712.
10] M.W.  Schwartz, S.C. Woods, D. Porte, R.J. Seeley, D.G. Baskin, Central
nervous system control of food intake, Nature 404 (2000) 661–671.
11] B. Challis, S. Pinnock, A. Coll, R. Carter, S. Dickson, et al., Acute effects
of  PYY3-36 on food intake and hypothalamic neuropeptide expression
in the mouse, Biochem. Biophys. Res. Commun. 311 (2003) 915–919.
12] G.J. Dockray, Cholecystokinin and gut-brain signalling, Regul. Pept.
155 (2009) 6–10.
13] A.D. Strader, S.C. Woods, Gastrointestinal hormones and food intake,
Gastroenterology 128 (2005) 175–191.
14] E. Valassi, M.  Scacchi, F. Cavagnini, Neuroendocrine control of food
intake, Nutr. Metab. Cardiovasc. Dis. 18 (2008) 158–168.
15] B.M. Flannery, E.S. Clark, J.J. Pestka, Anorexia induction by the tri-
chothecene deoxynivalenol (vomitoxin) is mediated by the release
of  the gut satiety hormone peptide YY (PYY), Toxicol. Sci. 130 (2012)
289–297.
16] W.  Wu,  H.-R. Zhou, K. He, X. Pan, Y. Sugita-Konishi, et al., Role of
cholecystokinin in anorexia induction following oral exposure to
the 8-ketotrichothecenes deoxynivalenol, 15-acetyldeoxynivalenol,
3-acetyldeoxynivalenol, fusarenon X and nivalenol, Toxicol. Sci. 138
(2014) 278–289.
17] R.A. Ellison, F.N. Kotsonis, In vitro metabolism of T-2 toxin, Appl.
Microbiol. 27 (1974) 423–424.
18] Y. Ueno, N. Sato, K. Ishii, K. Sakai, H. Tsunoda, et al., Biological and
chemical detection of trichothecene mycotoxins of Fusarium species,
Appl. Microbiol. 25 (1973) 699.
19] J. Greenway, R. Puls, Fusariotoxicosis from barley in British Columbia.
I. Natural occurrence and diagnosis, Can. J. Comp. Med. 40 (1976) 12.
20] I.-C. Hsu, E. Smalley, F. Strong, W.E. Ribelin, Identiﬁcation of T-2 toxin
in moldy corn associated with a lethal toxicosis in dairy cattle, Appl.
Microbiol. 24 (1972) 684–690.
21] Y. Ueno, Mode of action of trichothecenes, Pure Appl. Chem. 49 (1977)
1737–1745.
22] Z.G. Wang, J.N. Feng, Z. Tong, Human toxicosis caused by moldy rice
contaminated with Fusarium and T-2 toxin, Biomed. Environ. Sci. 6
(1)  (1993) 65–70.
23] S. Fairhurst, T. Marrs, H. Parker, J. Scawin, D. Swanston, Acute toxicity
of  T2 toxin in rats, mice, guinea pigs, and pigeons, Toxicology 43
(1987) 31–49.24] I.I. Lutsky, N. Mor, Alimentary toxic aleukia (septic angina, endemic
panmyelotoxicosis, alimentary hemorrhagic aleukia): t-2 toxin-
induced intoxication of cats, Am.  J. Pathol. 104 (1981) 189–191.
25] S. Gaigé, M.  Djelloul, C. Tardivel, C. Airault, B. Félix, et al., Modiﬁca-
tion of energy balance induced by the food contaminant T-2 toxin: a
gy Repo
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[W.  Wu  et al. / Toxicolo
multimodal gut-to-brain connection, Brain Behav. Immun. 37 (2014)
54–72.
26] P. Gentry, M.  Cooper, Effect of Fusarium T-2 toxin on hematologi-
cal  and biochemical parameters in the rabbit, Can. J. Comp. Med. 45
(1981) 400.
27] N. Sato, Y. Ueno, M.  Enomoto, Toxicological approaches to the toxic
metabolites of Fusaria. VIII. Acute and subacute toxicities of T-2 toxin
in  cats, Jpn. J. Pharmacol. 25 (1975) 263–270.
28] EFSA, Scientiﬁc opinion on the risks for animal and public health
related to the presence of T-2 and HT-2 toxin in food and feed, EFSA
J.  9 (2011) 1–187.
29] J.J. Pestka, J.H. Forsell, Inhibition of human lymphocyte transforma-
tion by the macrocyclic trichothecenes roridin A and verrucarin A,
Toxicol. Lett. 41 (1988) 215–222.
30] S.A. Carey, C.G. Plopper, D.M. Hyde, Z. Islam, J.J. Pestka, et al., Satra-
toxin G from the black mold Stachybotrys chartarum induces rhinitis
and apoptosis of olfactory sensory neurons in the nasal airways of
rhesus monkeys, Toxicol. Pathol. 40 (2012) 887–898.
31] K.N. Corps, Z. Islam, J.J. Pestka, J.R. Harkema, Neurotoxic, inﬂam-
matory, and mucosecretory responses in the nasal airways of mice
repeatedly exposed to the macrocyclic trichothecene mycotoxin ror-
idin  A: dose-response and persistence of injury, Toxicol. Pathol. 38
(2010) 429–451.
32] Z. Islam, J.R. Harkema, J.J. Pestka, Satratoxin G from the black mold
Stachybotrys chartarum evokes olfactory sensory neuron loss and
inﬂammation in the murine nose and brain, Environ. Health Perspect.
114 (2006) 1099–1107.
33] C. Jia, S. Sangsiri, B. Belock, T.R. Iqbal, J.J. Pestka, et al., ATP mediates
neuroprotective and neuroproliferative effects in mouse olfactory
epithelium following exposure to satratoxin G in vitro and in vivo,
Toxicol. Sci. 124 (2011) 169–178.
34] K. Bhargava, P. Gupta, O. Chandra, Effect of ablation of the
chemoreceptor trigger zone (CT zone) on the emetic response to
intraventricular injection of apomorphine and emetine in the dog,
J. Pharmacol. Exp. Ther. 134 (1961) 329–331.
35] R. Neal, Experimental amoebiasis and the development of anti-
amoebic compounds, Parasitology 86 (1983) 175–191.
36] R.S. Gupta, L. Siminovitch, The molecular basis of emetine resistance
in Chinese hamster ovary cells: alteration in the 40S ribosomal sub-
unit, Cell 10 (1977) 61–66.
37] B.M. Flannery, W.  Wu,  J.J. Pestka, Characterization of deoxynivalenol-
induced anorexia using mouse bioassay, Food Chem. Toxicol. 49
(2011) 1863–1869.38] W.  Wu,  B.M. Flannery, Y. Sugita-Konishi, M.  Watanabe, H.
Zhang, et al., Comparison of murine anorectic responses to the
8-ketotrichothecenes 3-acetyldeoxynivalenol, 15-acetyldeoxy-
nivalenol, fusarenon X and nivalenol, Food Chem. Toxicol. 50 (2012)
2056–2061.
[rts 2 (2015) 238–251 251
39] Z. Islam, J. Shinozuka, J.R. Harkema, J.J. Pestka, Puriﬁcation and com-
parative neurotoxicity of the trichothecenes satratoxin G and roridin
L2 from Stachybotrys chartarum, J. Toxicol. Environ. Health Part A 72
(20) (2009) 1242–1251.
40] A. Sintov, M.  Bialer, B. Yagen, Pharmacokinetics of T-2 toxin and
its  metabolite HT-2 toxin, after intravenous administration in dogs,
Drug Metab. Dispos. 14 (1986) 250–254.
41] S. Yang, Y. Li, X. Cao, et al., Metabolic pathways of T-2 toxin in in vivo
and in vitro systems of Wistar rats, J. Agric. Food Chem. 61 (40) (2013)
9734–9743.
42] C.A. Knupp, S.P. Swanson, W.B. Buck, Comparative in vitro
metabolism of T-2 toxin by hepatic microsomes prepared from
phenobarbital-induced or control rats, mice, rabbits and chickens,
Food Chem. Toxicol. 25 (1987) 859–865.
43] C.J. Amuzie, Z. Islam, J. Kim, J. Seo, J.J. Pestka, Kinetics of satratoxin
G tissue distribution and excretion following intranasal exposure in
the  mouse, Toxicol. Sci. 116 (2010) 433–440.
44] K.W. Kelley, R.-M. Bluthé, R. Dantzer, J.-H. Zhou, W.-H. Shen, et al.,
Cytokine-induced sickness behavior, Brain Behav. Immun. 17 (2003)
112–118.
45] C.R. Plata-Salaman, Cytokines and anorexia: a brief overview, Semin.
Oncol. 25 (1 Suppl. 1) (1998) 64–72.
46] C.R. Plata-Salamán, G. Sonti, J.P. Borkoski, C.D. Wilson, J. MH Ffrench-
Mullen, Anorexia induced by chronic central administration of
cytokines at estimated pathophysiological concentrations, Physiol.
Behav. 60 (1996) 867–875.
47] G. Sonti, S. Ilyin, C. Plata-Salamán, Anorexia induced by cytokine
interactions at pathophysiological concentrations, Am.  J. Physiol. 270
(1996) R1394–R1402.
48] M.  Agrawal, P. Yadav, V. Lomash, A. Bhaskar, P. Lakshmana Rao, T-
2 toxin induced skin inﬂammation and cutaneous injury in mice,
Toxicology 302 (2012) 255–265.
49] S.M. Albarenque, K. Suzuki, H. Nakayama, K. Doi, Kinetics of cytokines
mRNAs expression in the dorsal skin of WBN/ILA-Ht rats follow-
ing  topical application of T-2 toxin, Exp. Toxicol. Pathol. 53 (2001)
271–274.
50] M.  Yen, M.B. Ewald, Toxicity of weight loss agents, J. Med. Toxicol. 8
(2012) 145–152.
51] W.  Wong, X.C. Bai, A. Brown, I.S. Fernandez, E. Hanssen, et al.,
Cryo-EM structure of the Plasmodium falciparum 80S ribosome
bound to the anti-protozoan drug emetine, eLife 3 (2014), e03080,
20 pp.
52] D.L. Leatherman, J.L. Middlebrook, Effect of emetine on T-2 toxin-
induced inhibition of protein synthesis in mammalian cells, J.
Pharmacol. Exp. Ther. 266 (1993) 741–748.
53] D.L. Leatherman, J.L. Middlebrook, Effects of emetine on the speciﬁc
association of T-2 toxin with mammalian cells, J. Pharmacol. Exp.
Ther. 266 (1993) 732–740.
